Literature DB >> 32504125

Resection margin histology may predict intermediate-term outcomes in children with rectosigmoid Hirschsprung disease.

Lauren A Brooks1, Kathryn L Fowler1, Laura V Veras1, Ming Fu1,2, Ankush Gosain3,4.   

Abstract

INTRODUCTION: Recent studies suggest that some of the post-surgical morbidity in Hirschsprung disease (HSCR) is due to enteric nervous system structural defects in the proximal, ganglionated bowel that remains after surgery. We hypothesized that resection margin histology would predict intermediate-term outcomes in HSCR patients.
METHODS: Following IRB approval, HSCR patients with rectosigmoid disease born between 2009 and 2016 were reviewed and tissue blocks were obtained for new analyses. Proximal resection margins were analyzed for ganglion size, Hu + neurons/ganglion, and % nitric oxide synthase (NOS) neurons/ganglion as compared to control (non-HSCR) patient samples. Chart reviews were performed for 1- and 2-year outcomes. Patients were contacted for survey to determine Rintala bowel function score.
RESULTS: 45 patients had recto-sigmoid disease and were further analyzed. HSCR patients had significantly smaller individual ganglion size (4533 μm2, range 1744-16,287 vs. 6492 μm2, range 1932-30,838, p = 0.0192) and fewer HuC/D + neurons per ganglion (15, range 5.2-34 vs. 21, range 5.2-6.7, p = 0.0214). HSCR patients demonstrated a markedly increased percentage of NOS (relaxation neurotransmitter) neurons (50, range 22-85 vs. 37, range 16-80, p = 0.0266). None of the histology measures correlated with presence/absence of constipation at 1-2 year follow-up (p = NS). However, smaller ganglion size and higher percentage of NOS neurons correlated with decreased patient-reported quality of life (r = 0.3838, r =  - 0.1809).
CONCLUSION: 1-2 year follow-up may be insufficient to determine if resection margin histology correlates with outcomes. Patient-reported quality of life surveys, although limited in number, suggest that neurotransmitter imbalance at the resection margin may predict poor outcomes in HSCR patients. This study supports the concept that the ganglionated portion of the remaining colon post-surgery may not sustain normal bowel function.

Entities:  

Keywords:  Aganglionosis; Enteric nervous system; Hirschsprung; Neurotransmitter; Quality of life

Mesh:

Year:  2020        PMID: 32504125      PMCID: PMC7332381          DOI: 10.1007/s00383-020-04689-x

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  12 in total

Review 1.  Guidelines for synoptic reporting of surgery and pathology in Hirschsprung disease.

Authors:  Laura V Veras; Michael Arnold; Jeffrey R Avansino; Kevin Bove; Robert A Cowles; Megan M Durham; Allan M Goldstein; Chandra Krishnan; Jacob C Langer; Marc Levitt; Hector Monforte-Munoz; Raja Rabah; Miguel Reyes-Mugica; Michael D Rollins; Raj P Kapur; Ankush Gosain
Journal:  J Pediatr Surg       Date:  2019-03-21       Impact factor: 2.545

2.  Resection of rectum and rectosigmoid with preservation of the sphincter for benign spastic lesions producing megacolon; an experimental study.

Authors:  O SWENSON; A H BILL
Journal:  Surgery       Date:  1948-08       Impact factor: 3.982

Review 3.  The enteric nervous system: normal functions and enteric neuropathies.

Authors:  J B Furness
Journal:  Neurogastroenterol Motil       Date:  2008-05       Impact factor: 3.598

Review 4.  Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes.

Authors:  Robert O Heuckeroth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-04       Impact factor: 46.802

5.  Bowel function and gastrointestinal quality of life among adults operated for Hirschsprung disease during childhood: a population-based study.

Authors:  Kristiina Jarvi; Elina M Laitakari; Antti Koivusalo; Risto J Rintala; Mikko P Pakarinen
Journal:  Ann Surg       Date:  2010-12       Impact factor: 12.969

6.  Bowel dysfunction following pullthrough surgery is associated with an overabundance of nitrergic neurons in Hirschsprung disease.

Authors:  Lily S Cheng; Dana M Schwartz; Ryo Hotta; Hannah K Graham; Allan M Goldstein
Journal:  J Pediatr Surg       Date:  2016-08-09       Impact factor: 2.545

7.  Is normal bowel function possible after repair of intermediate and high anorectal malformations?

Authors:  R J Rintala; H Lindahl
Journal:  J Pediatr Surg       Date:  1995-03       Impact factor: 2.545

8.  Altered neuronal density and neurotransmitter expression in the ganglionated region of Ednrb null mice: implications for Hirschsprung's disease.

Authors:  I Zaitoun; C S Erickson; A J Barlow; T R Klein; A F Heneghan; J F Pierre; M L Epstein; A Gosain
Journal:  Neurogastroenterol Motil       Date:  2013-01-29       Impact factor: 3.598

9.  Social Morbidity in Relation to Bowel Functional Outcomes and Quality of Life in Anorectal Malformations and Hirschsprung's Disease.

Authors:  Kristiina Kyrklund; Malla I Neuvonen; Mikko P Pakarinen; Risto J Rintala
Journal:  Eur J Pediatr Surg       Date:  2017-10-23       Impact factor: 2.191

10.  A 5-year follow-up study of neonates with Hirschsprung's disease undergoing transanal Soave or Swenson surgery.

Authors:  Jianjun Zhang; Tongsheng Ma; Yuan Peng; Guangfeng Huang; Fengli Liu
Journal:  Patient Prefer Adherence       Date:  2017-11-29       Impact factor: 2.711

View more
  1 in total

Review 1.  Current understanding of Hirschsprung-associated enterocolitis: Pathogenesis, diagnosis and treatment.

Authors:  Ruth A Lewit; Korah P Kuruvilla; Ming Fu; Ankush Gosain
Journal:  Semin Pediatr Surg       Date:  2022-04-08       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.